Target intelligence / Profile preview

Tek gene-derived cis-regulatory enhancer element (Tie2 enhancer)

Target
Tie2 enhancer
Molecular classification
Cis-regulatory element, DNA sequence, Enhancer
01

Overview

The Tek gene-derived cis-regulatory enhancer element is a genomic DNA sequence that controls the spatio-temporal expression of the Tek (also known as Tie2) receptor tyrosine kinase (Schlaeger et al., 1997, PNAS). This enhancer is highly specific to endothelial cells and certain hematopoietic lineages, making it a critical tool in vascular biology research for driving the expression of transgenes specifically in blood vessels (De Palma et al., 2003, Nature Medicine). While the Tek protein is a well-known therapeutic target for its role in angiogenesis and vascular stability, the enhancer element itself is not a target for conventional small molecule or antibody drugs. Instead, it serves as a foundational component in the design of gene therapy vectors aimed at treating diseases with a strong vascular component, such as solid tumors or ischemic disorders (Minami et al., 2003, Journal of Biological Chemistry). Its activity is regulated by a complex interplay of transcription factors, including members of the Ets and GATA families, which bind to specific motifs within the enhancer to initiate transcription (Iljin et al., 1999, FASEB Journal). In biotechnology, the 2.1-kb fragment of this enhancer is the most commonly used version for creating endothelial-specific transgenic mouse lines. Mutations or deletions in such regulatory elements can lead to dysregulated gene expression, potentially contributing to vascular malformations or altered angiogenic responses in disease states. Understanding the precise sequence and function of this element allows researchers to refine targeted delivery systems for genetic medicine.

Other names
Tie2 enhancerTek enhancerEndothelial-specific Tek enhancerTie2 promoter-enhancerTek-derived endothelial enhancer
02

Mechanism of action

Not applicable as this is a DNA regulatory element and not a protein target for pharmacological intervention.

03

Biological functions

Regulation of gene expressionEndothelial cell differentiationAngiogenesisVasculogenesisHematopoiesis
04

Disease associations

Vascular diseaseCancerIschemiaVascular malformation
05

Safety considerations

Ectopic expression in non-target tissues when used in gene therapy vectorsPotential for insertional mutagenesis in genomic applicationsVariable activity in different vascular beds

Beyond the preview

Go deeper on Tek gene-derived cis-regulatory enhancer element (Tie2 enhancer).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tek gene-derived cis-regulatory enhancer element (Tie2 enhancer).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call